| Home | E-Submission | Sitemap | Contact Us |  
Instructions for Authors > For Authors and Reviewers > Instructions for Authors


All manuscripts should be submitted online (http://www.jpatholtm.org), and should meet the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/).

Manuscripts should be written in English. Authors from non-English speaking countries are encouraged to have their manuscripts proofread by professional English editors. The medical terms of Korean authors should be in accordance with the glossary published by the Korean Medical Association. The Editors may return the manuscript to the authors before the review process when the content, format, and grammar of the manuscript do not conform to the guidelines or when a breach of publication ethics is present.


The journal adheres to the ethical guidelines for research and publication described in Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/intro.php?body=publishing_ethics) and Guidelines on Good Publication (http://publicationethics.org/resources/guidelines).

1) Ethical Approval

All studies on human subjects should follow the World Medical Association Declaration of Helsinki (1964) and the authors should provide an affirmation that the studies have been approved by the appropriate institutional review board (IRB) and/or national research ethics committee with relevant reference numbers and dates. The following statement should be included in the text at the end of the Materials and Methods section: "All procedures performed in the current study were approved by IRB and/or national research ethics committee (reference number and date) in accordance with the 1964 Helsinki declaration and its later amendments."

2) Informed Consent

Authors should have obtained written informed consent from all participants prior to inclusion in the study, and the following statement should be included at the end of the Materials and Methods section after the IRB approval statement: 쏧nformed consent was obtained from all individual participants included in the study. Identifying details of the participants (e.g. names, dates of birth, and unit numbers) should not be published in written descriptions, photographs, and genetic profiles. In cases where identifying details are essential for scientific purposes, the participant should have given written informed consent for the identifying information to be published and it should be stated separately as following: "Additional informed consent was obtained from all individual participants for whom identifying information is included in this article." Waiver of the informed consent can only be granted by the appropriate IRB and/or national research ethics committee in compliance with the current laws of the country in which the study was performed, and this should be separately stated as following: 쏤ormal written informed consent was not required with a waiver by the appropriate IRB and/or national research ethics committee. It should be noted that manuscripts that do not contain statements on IRB approval and patient informed consent can be returned to the authors before the review process. For autopsy case reports, an informed consent is not required under the premises that consent was previously obtained for the autopsy to be conducted and that the strict anonymity of the patient has been respected.

3) Disclosure of Potential Conflicts of Interest

A statement disclosing all relationships or interests that could have direct or potential influence on the work should be included in a separate section before the reference list. For funding, the following statement must be included: 쏷his study was funded by X (grant number X). For potential conflict of interest, a specific disclosure must be stated as following: "Author A has received a research grant from Company X.", "Author A owns stock in Company X.", or "Author A is a member of the Committee X." If there is no potential conflict of interest, the following should be stated: 쏷he authors declare that they have no conflict of interest.

The authors will be held responsible for any false statements or failure to follow the ethical guidelines.

Animal studies also need to be approved by the institutional Animal Ethics Committee (AEC) or its equivalent. Each author should have participated in the research and/or article preparation. All authors are responsible for disclosing any conflict of interest that could influence the content of papers. All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.


Received manuscripts will be peer-reviewed and a primary editorial decision will be sent to the authors within 2 weeks after submission. All articles will be published within 2 months after final acceptance by the Editorial Office.


Manuscripts should be submitted as Microsoft Word files (doc, docx). Standard metric units (International System of Units; SI units) should be used

1) Title page

The title page must include the full title; all authors full names (first name, middle initial, last name); the institutional affiliations of all authors; a running title (less than 40 characters); the name and address of author(s) to whom correspondence should be sent; and ORCID (Open Researcher and Contributor ID, all authors). Please refer to http://orcid.org. Grant support must be placed as a footnote.

2) Abstract/Key Words

An abstract must not exceed 250 words. A structured format is preferred with subheadings of 'Background', 'Methods', 'Results', and 'Conclusions'. List three to five key words, selected from the Medical Subject Headings (MeSH) of Index Medicus.

3) Text

The manuscripts should be composed of the following sections, which begin on separate pages: 'Introduction', 'Materials and Methods', 'Results', and 'Discussion'. If the authors work contains human or animal studies, it must be stated that the studies have been approved by institutional review committees in the Materials and Methods section.

Clearly describe the selection of observational or experimental participants (healthy individuals or patients, including controls), including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age, sex, or ethnicity is not always known at the time of study design, researchers should aim for inclusion of representative populations into all study types and at a minimum provide descriptive data for these and other relevant demographic variables.

Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.

4) Acknowledgments (optional)

5) References

References are numbered in the order of citation within the article. Citations in the main text must appear as superscripted Arabic numerals at the end of the sentence or immediately after the authors' name. References with up to six authors must list all names; for more than six authors, list the names of the first three authors followed by et al. Periodical abbreviations should follow those used by Index Medicus. Individual references should be formatted in Vancouver style as follows:

Endnote Style

Journal articles

1. Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, Offerhaus GJ, Rodenhuis S. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst 1991; 83: 1024-7.


2. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins pathologic basis of disease. 8th ed. Philadelphia: Saunders-Elsevier, 2010; 79-86.

Book chapters

3. Frosch MP, Anthony DC, De Girolami U. The central nervous system. In: Kumar V, Abbas AK, Fausto N, Aster JC, eds. Robbins pathologic basis of disease. 8th ed. Philadelphia: Saunders-Elsevier, 2010; 1279-344.

Internet resources

4. Medicare now covers HIV tests [Internet]. Chicago: American Medical Association, c1995-2010 [cited 2010 Jan 28]. Available from: http://www.ama-assn.org/amednews/2009/12/21/gvsf1223.htm.

6) Tables

Each table should appear on a separate page.

7) Figures

Authors must submit illustrations as electronic files. Images should be provided as TIFF files, but JPEG is also acceptable when the original format is JPEG. When authors need to arrange figures in certain ways, they can submit figures in prearranged ppt/pptx files. Each figure needs to be prepared in a resolution higher than 300 dpi with good contrast and sharpness. Figures that are reproduced from other published resources require written permission from the authors and copyright holders.


1. Original articles

2. Reviews and Editorials

Reviews and Editorials are invited only. Manuscripts must include the following: (1) title page, (2) abstract (not more than 250 words) and keywords, (3) introduction, (4) main text, (5) conclusion and (6) references. There are no restrictions to the number and size of the figures.

3. Case Studies / Brief case reports

A small series or a single case with unique pathological aspect and in-depth scientific content including genetic analysis or literature review can be reported as Case Studies. The manuscripts must include the following: (1) abstract (one paragraph, not more than 150 words), (2) introduction, (3) case description, (4) discussion, and (5) references (not more than 20). Illustrations should be no more than three. Authors may be asked to revise and resubmit the manuscript as Brief Case Reports in accordance with editorial policy. A brief case report should consist of a brief case description and discussion without abstract, in no more than 800 words with illustrations (no more than 3) and references (no more than 10). For manuscripts submitted for consideration in this section, the institutional review board (IRB) approval can be waived. However, personal information of the patient(s) must be de-identified or the patient셲 written authorization to allow information on their case to be published should be supplied.

4. Letters to the Editors

The Editors welcome brief letters (not more than two A4 pages in length) commenting on articles appearing in recent issues, on general interests for pathologists, and personal opinions on specific topics. Those letters selected for publication will first be referred to the author of the paper in question, whose response may also be published.


Original articles and reviews are exempt from the publication charges. For others (case studies, brief case reports and letters), page charges are $150 per 4 printed pages or less and $25 per additional page. The surcharge for color figures is $100 per page. The charge for print copies of each article is $50 per printed 50 copies and the surcharge is $10 per additional copy.


All manuscripts should be submitted through the web site of the Journal of Pathology and Translational Medicine (www.jpatholtm.org).

Inquiries about the manuscript submission and processing can be sent to Editorial Office:
Journal of Pathology and Translational Medicine
Room 1209 Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea /
#1508 Renaissancetower, 14, Mallijae-ro, Mapo-gu, Seoul 04195, Korea
Tel: +82-2-795-3094 / +82-2-593-6943,      Fax: +82-2-790-6635 / +82-2-593-6944,     E-mail: office@jpatholtm.org

Endnote Style
Email Alert
Author's Index
SCImago Journal & Country Rank
PubMed Central
Directory of Open Access Journals
Similarity Check
Crossref Cited-by Linking
Funder Registry